Total planned funding: $2,053,075,272
Clear active filters
Private Contractor
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $338,576,827 |
Tanzania | $298,589,359 |
Zambia | $250,208,981 |
Mozambique | $168,127,109 |
Uganda | $140,140,316 |
Kenya | $135,413,829 |
South Africa | $111,881,428 |
Ethiopia | $102,722,136 |
Côte d'Ivoire | $86,642,188 |
Zimbabwe | $83,675,356 |
Rwanda | $75,924,404 |
Vietnam | $38,506,226 |
Haiti | $37,621,251 |
Botswana | $31,947,729 |
Namibia | $28,639,219 |
Eswatini | $24,258,906 |
Democratic Republic of the Congo | $23,778,549 |
Malawi | $12,686,616 |
Ukraine | $10,834,379 |
Central America Region | $7,399,486 |
Guyana | $6,253,749 |
Ghana | $5,398,467 |
Lesotho | $5,190,000 |
Burundi | $4,479,501 |
South Sudan | $4,204,098 |
Angola | $3,700,000 |
Cameroon | $3,118,897 |
Indonesia | $2,860,000 |
India | $2,448,272 |
Caribbean Region | $2,431,844 |
Cambodia | $2,350,000 |
Russia | $1,850,000 |
China | $716,150 |
Burma | $500,000 |
Central Asia Region | $0 |
Thailand | $0 |
Dominican Republic | $0 |
Organizational Types
Private Contractor | $2,053,075,272 |
Program Areas
Treatment | $1,121,760,650 |
Governance and Systems | $343,134,770 |
Care | $261,992,952 |
Prevention | $197,660,973 |
Testing | $125,069,810 |
Budget Codes
HTXD: Treatment: ARV Drugs | $852,169,129 |
HTXS: Treatment: Adult Treatment | $242,965,080 |
OHSS: Health Systems Strengthening | $184,437,736 |
HVCT: Testing: HIV Testing and Counseling | $125,069,810 |
HBHC: Care: Adult Care and Support | $121,297,425 |
HLAB: Laboratory Infrastructure | $103,305,161 |
HKID: Care: Orphans and Vulnerable Children | $79,934,552 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $63,501,648 |
HVSI: Strategic Information | $55,391,873 |
HVTB: Care: TB/HIV | $49,484,549 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $44,574,408 |
HVOP: Sexual Prevention: Other Sexual Prevention | $38,162,341 |
PDTX: Treatment: Pediatric Treatment | $26,626,441 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $24,107,106 |
HMIN: Biomedical Prevention: Injection Safety | $17,120,877 |
PDCS: Care: Pediatric Care and Support | $11,276,426 |
HMBL: Biomedical Prevention: Blood Safety | $5,108,609 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $5,085,984 |
Top Partner Programs
Chemonics International:
$705,230,919
View countries
John Snow, Inc:
$69,963,283
View countries
Abt Associates:
$56,834,182
View countries